NetworkNewsBreaks – Magenta Therapeutics Inc. (NASDAQ: MGTA) Featured in Mizuho Securities Research Report
Magenta Therapeutics (NASDAQ: MGTA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are updating our MGTA company model after assuming research coverage of the company and also incorporating updates related to the company's revised operating plan. We agree with their efforts to emphasize the MGTA-117 targeted conditioning program, given its potentially transformative nature. Management will also continue IND-enabling activities for their CD45-ADC and MGTA-145 stem cell mobilization efforts in sickle cell disease but will de-prioritize other investments to navigate the challenging capital market environment and extend their expected cash runway…







